Consano Clinical Research, LLC
1 clinical trials · Sponsor
◉ Watch Consano Clinical Research, LLC
| Record | Firm | Date |
|---|---|---|
| Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept. (NCT03970044) | Consano Clinical Research, LLC | 2019-07-02 |
Track Consano Clinical Research, LLC automatically
Every clearance here is in the API, with alerts when new ones post.